About AVT
Browse Articles
Authors
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
 
Displaying 70 results:

Short communication

Prevalence of sofosbuvir resistance-associated variants in Brazilian and world-wide NS5B sequences of genotype-1 HCV

Allan Peres-da-Silva, Carlos Eduardo Brandão-Mello, Elisabeth Lampe

10.3851/IMP3131


Case report

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy

Stefania Paolucci, Marta Premoli, Serena Ludovisi, Mario U Mondelli, Fausto Baldanti

10.3851/IMP3130


Original article

The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation

Tomas Reischig, Martin Kacer, Petra Hruba, Pavel Jindra, Ondrej Hes, Daniel Lysak, Mirko Bouda, Ondrej Viklicky

10.3851/IMP3129


Original article

Viral blips were infrequent in treatment-naive adults treated with rilpivirine/emtricitabine/ tenofovir DF or efavirenz/emtricitabine/ tenofovir DF through 96 weeks

Danielle P Porter, Rima Kulkarni, Will Garner, Michael D Miller, Kirsten L White

10.3851/IMP3128


Short communication

Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/ tenofovir disoproxil fumarate

Nicolas Margot, Stephanie Cox, Moupali Das, Scott McCallister, Michael D Miller, Christian Callebaut

10.3851/IMP3125


Original article

Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study

Vasantha Jotwani, Rebecca Scherzer, Michelle M Estrella, Lisa P Jacobson, Mallory D Witt, Frank Palella, Ken Ho, Michael Bennett, Chirag R Parikh, Joachim H Ix, Michael Shlipak

10.3851/IMP3124


Original article

HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients

Yael Gozlan, Ziv Ben-Ari, Roy Moscona, Rachel Shirazi, Avia Rakovsky, Arij Kabat, Ella Veizman, Tania Berdichevski, Peretz Weiss, Oranit Cohen-Ezra, Yoav Lurie, Inna Gafanovich, Marius Braun, Michal Cohen-Naftaly, Amir Shlomai, Oren Shibolet, Ehud Zigmond, Eli Zuckerman, Michal Carmiel-Haggai, Assy Nimer, Rawi Hazzan, Yaakov Maor, Yona Kitay-Cohen, Yonat Shemer, Zipi Kra-Oz, Lisita Schreiber, Ofer Peleg, Ella Mendelson, Orna Mor

10.3851/IMP3123


Case report

Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for TDM

Francesco R Simonetti, Dario Cattaneo, Nadia Zanchetta, Vania Giacomet, Valeria Micheli, Nadia Ciminera, Cristina Gervasoni

10.3851/IMP3122


Original article

Life expectancy after initiation of combination antiretroviral therapy in Thailand

Sirinya Teeraananchai, Suchada Chaivooth, Stephen J Kerr, Sorakij Bhakeecheep, Anchalee Avihingsanon, Achara Teeraratkul, Petchsri Sirinirund, Matthew G Law, Kiat Ruxrungtham

10.3851/IMP3121


Original article

Effect of minor populations of NS5A and NS5B resistance-associated variants on HCV genotype-3 response to daclatasvir plus sofosbuvir, with or without ribavirin

Fiona McPhee, Dennis Hernandez, Nannan Zhou

10.3851/IMP3120


Page:
Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.